Campbell EM. 2016. TRIM5α degradation via autophagy is not required for retroviral restriction

Journal of Virology

Volumn 90, Issue 7, 2016, Pages 3400-3410

  Imam, Sabrina ^a   Talley, Sarah ^a   Nelson, Rachel S ^a   Dharan, Adarsh ^a   O'Connor, Christopher ^b   Hope, Thomas J ^c   Campbell, Edward M ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b MARYVILLE UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOPHAGY PROTEIN 5; BAFILOMYCIN A1; BECLIN 1; BIOLOGICAL MARKER; LC3B; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; PROTEASOME; PROTEIN P62; SMALL INTERFERING RNA; TRIPARTITE MOTIF PROTEIN 5; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; ATG5 PROTEIN, HUMAN; AUTOPHAGY RELATED PROTEIN 5; BECN1 PROTEIN, HUMAN; CARRIER PROTEIN; CORE PROTEIN; LAMP3 PROTEIN, HUMAN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN; MACROLIDE; MAP1LC3B PROTEIN, HUMAN; MEMBRANE PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; P62 PROTEIN, HUMAN; RNA BINDING PROTEIN; TRIM5 PROTEIN, HUMAN; TUMOR PROTEIN;

ANIMAL CELL; ARTICLE; AUTOPHAGY; CELLULAR STRESS RESPONSE; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; CONTROLLED STUDY; CYTOPLASM; EMBRYO; HELA CELL LINE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LYSOSOME; MACROAUTOPHAGY; MOUSE; MURINE LEUKEMIA VIRUS; N TROPIC MURINE LEUKEMIA VIRUS; NONHUMAN; OWL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; RETROVIRAL RESTRICTION; REVERSE TRANSCRIPTION; RHESUS MONKEY; SPECIES DIFFERENCE; VIRAL PHENOMENA AND FUNCTIONS; VIRUS CAPSID; VIRUS GENOME; VIRUS REPLICATION; WILD TYPE; ANIMAL; AOTIDAE; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; METABOLISM; RETROVIRIDAE; RETROVIRUS INFECTION; RNA INTERFERENCE; TUMOR CELL LINE; VIROLOGY;

ANIMALS; AOTIDAE; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; AUTOPHAGY-RELATED PROTEIN 5; BECLIN-1; CARRIER PROTEINS; CELL LINE, TUMOR; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS; HELA CELLS; HUMANS; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; MACACA MULATTA; MACROLIDES; MEMBRANE PROTEINS; MICE; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; PROTEOLYSIS; RETROVIRIDAE; RETROVIRIDAE INFECTIONS; RNA INTERFERENCE; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; VIRAL CORE PROTEINS; VIRUS REPLICATION;

EID: 84960968603     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03033-15     Document Type: Article

References (44)

1. McNab FW, Rajsbaum R, Stoye JP, O'Garra A. 2011. Tripartite-motif proteins and innate immune regulation. Curr Opin Immunol 23:46-56. http://dx.doi.org/10.1016/j.coi.2010.10.021.
2. Napolitano LM, Meroni G. 2012. TRIM family: pleiotropy and diversification through homomultimer and heteromultimer formation. IUBMB Life 64:64-71. http://dx.doi.org/10.1002/iub.580.
3. Kimura T, Jain A, Choi SW, Mandell MA, Schroder K, Johansen T, Deretic V. 2015. TRIM-mediated precision autophagy targets cytoplasmic regulators of innate immunity. J Cell Biol 210:973-989. http://dx.doi.org/10.1083/jcb.201503023.
4. Ozato K, Shin DM, Chang TH, Morse HC, III. 2008. TRIM family proteins and their emerging roles in innate immunity. Nat Rev Immunol 8:849-860. http://dx.doi.org/10.1038/nri2413.
5. Carthagena L, Bergamaschi A, Luna JM, David A, Uchil PD, Margottin-Goguet F, Mothes W, Hazan U, Transy C, Pancino G, Nisole S. 2009. Human TRIM gene expression in response to interferons. PLoS One 4:e4894. http://dx.doi.org/10.1371/journal.pone.0004894.
6. Rajsbaum R, Stoye JP, O'Garra A. 2008. Type I interferon-dependent and-independent expression of tripartite motif proteins in immune cells. Eur J Immunol 38:619-630. http://dx.doi.org/10.1002/eji.200737916.
7. Uchil PD, Hinz A, Siegel S, Coenen-Stass A, Pertel T, Luban J, Mothes W. 2013. TRIM protein-mediated regulation of inflammatory and innate immune signaling and its association with antiretroviral activity. J Virol 87:257-272. http://dx.doi.org/10.1128/JVI.01804-12.
8. Versteeg GA, Rajsbaum R, Sanchez-Aparicio MT, Maestre AM, Valdiviezo J, Shi M, Inn KS, Fernandez-Sesma A, Jung J, Garcia-Sastre A. 2013. The E3-ligase TRIM family of proteins regulates signaling pathways triggered by innate immune pattern-recognition receptors. Immunity 38: 384-398. http://dx.doi.org/10.1016/j.immuni.2012.11.013.
9. Fletcher AJ, Christensen DE, Nelson C, Tan CP, Schaller T, Lehner PJ, Sundquist WI, Towers GJ. 2015. TRIM5alpha requires Ube2W to anchor Lys63-linked ubiquitin chains and restrict reverse transcription. EMBO J 34:2078-2095. http://dx.doi.org/10.15252/embj.201490361.
10. Diaz-Griffero F, Qin XR, Hayashi F, Kigawa T, Finzi A, Sarnak Z, Lienlaf M, Yokoyama S, Sodroski J. 2009. A B-box 2 surface patch important for TRIM5alpha self-association, capsid binding avidity, and retrovirus restriction. J Virol 83:10737-10751. http://dx.doi.org/10.1128/JVI.01307-09.
11. Javanbakht H, Yuan W, Yeung DF, Song B, Diaz-Griffero F, Li Y, Li X, Stremlau M, Sodroski J. 2006. Characterization of TRIM5alpha trimerization and its contribution to human immunodeficiency virus capsid binding. Virology 353:234-246. http://dx.doi.org/10.1016/j.virol.2006.05.017.
12. Kar AK, Mao Y, Bird G, Walensky L, Sodroski J. 2011. Characterization of a core fragment of the rhesus monkey TRIM5alpha protein. BMC Biochem 12:1. http://dx.doi.org/10.1186/1471-2091-12-1.
13. Langelier CR, Sandrin V, Eckert DM, Christensen DE, Chandrasekaran V, Alam SL, Aiken C, Olsen JC, Kar AK, Sodroski JG, Sundquist WI. 2008. Biochemical characterization of a recombinant TRIM5alpha protein that restricts human immunodeficiency virus type 1 replication. J Virol 82:11682-11694. http://dx.doi.org/10.1128/JVI.01562-08.
14. Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, Luzi L, Riganelli D, Zanaria E, Messali S, Cainarca S, Guffanti A, Minucci S, Pelicci PG, Ballabio A. 2001. The tripartite motif family identifies cell compartments. EMBO J 20:2140-2151. http://dx.doi.org/10.1093/emboj/20.9.2140.
15. Sawyer SL, Wu LI, Emerman M, Malik HS. 2005. Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain. Proc Natl Acad Sci U S A 102:2832-2837. http://dx.doi.org/10.1073/pnas.0409853102.
16. Song B, Javanbakht H, Perron M, Park DH, Stremlau M, Sodroski J. 2005. Retrovirus restriction by TRIM5alpha variants from Old World and New World primates. J Virol 79:3930-3937. http://dx.doi.org/10.1128/JVI.79.7.3930-3937.2005.
17. Stremlau M, Perron M, Welikala S, Sodroski J. 2005. Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction. J Virol 79:3139-3145. http://dx.doi.org/10.1128/JVI.79.5.3139-3145.2005.
18. Hatziioannou T, Perez-Caballero D, Yang A, Cowan S, Bieniasz PD. 2004. Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha. Proc Natl Acad Sci U S A 101:10774-10779. http://dx.doi.org/10.1073/pnas.0402361101.
19. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J. 2004. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427:848-853. http://dx.doi.org/10.1038/nature02343.
20. Sayah DM, Sokolskaja E, Berthoux L, Luban J. 2004. Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature 430:569-573. http://dx.doi.org/10.1038/nature02777.
21. Anderson JL, Campbell EM, Wu X, VandegraaffN, Engelman A, Hope TJ. 2006. Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins. J Virol 80:9754-9760. http://dx.doi.org/10.1128/JVI.01052-06.
22. Campbell EM, Perez O, Anderson JL, Hope TJ. 2008. Visualization of a proteasome-independent intermediate during restriction of HIV-1 by rhesus TRIM5alpha. J Cell Biol 180:549-561. http://dx.doi.org/10.1083/jcb.200706154.
23. Wu X, Anderson JL, Campbell EM, Joseph AM, Hope TJ. 2006. Proteasome inhibitors uncouple rhesus TRIM5alpha restriction of HIV-1 reverse transcription and infection. Proc Natl Acad Sci U S A 103:7465-7470. http://dx.doi.org/10.1073/pnas.0510483103.
24. Roa A, Hayashi F, Yang Y, Lienlaf M, Zhou J, Shi J, Watanabe S, Kigawa T, Yokoyama S, Aiken C, Diaz-Griffero F. 2012. RING domain mutations uncouple TRIM5alpha restriction of HIV-1 from inhibition of reverse transcription and acceleration of uncoating. J Virol 86:1717-1727. http://dx.doi.org/10.1128/JVI.05811-11.
25. Rold CJ, Aiken C. 2008. Proteasomal degradation of TRIM5alpha during retrovirus restriction. PLoS Pathog 4:e1000074. http://dx.doi.org/10.1371/journal.ppat.1000074.
26. Lukic Z, Hausmann S, Sebastian S, Rucci J, Sastri J, Robia SL, Luban J, Campbell EM. 2011. TRIM5alpha associates with proteasomal subunits in cells while in complex with HIV-1 virions. Retrovirology 8:93. http://dx.doi.org/10.1186/1742-4690-8-93.
27. O'Connor C, Pertel T, Gray S, Robia SL, Bakowska JC, Luban J, Campbell EM. 2010. p62/sequestosome-1 associates with and sustains the expression of retroviral restriction factor TRIM5alpha. J Virol 84:5997-6006. http://dx.doi.org/10.1128/JVI.02412-09.
28. Mandell MA, Jain A, Arko-Mensah J, Chauhan S, Kimura T, Dinkins C, Silvestri G, Munch J, KirchhoffF, Simonsen A, Wei Y, Levine B, Johansen T, Deretic V. 2014. TRIM proteins regulate autophagy and can target autophagic substrates by direct recognition. Dev Cell 30:394-409. http://dx.doi.org/10.1016/j.devcel.2014.06.013.
29. Park C, Cuervo AM. 2013. Selective autophagy: talking with the UPS. Cell Biochem Biophys 67:3-13. http://dx.doi.org/10.1007/s12013-013-9623-7.
30. Korolchuk VI, Menzies FM, Rubinsztein DC. 2010. Mechanisms of crosstalk between the ubiquitin-proteasome and autophagy-lysosome systems. FEBS Lett 584:1393-1398. http://dx.doi.org/10.1016/j.febslet.2009.12.047.
31. Campbell EM, Dodding MP, Yap MW, Wu X, Gallois-Montbrun S, Malim MH, Stoye JP, Hope TJ. 2007. TRIM5 alpha cytoplasmic bodies are highly dynamic structures. Mol Biol Cell 18:2102-2111. http://dx.doi.org/10.1091/mbc. E06-12-1075.
32. Sastri J, O'Connor C, Danielson CM, McRaven M, Perez P, Diaz-Griffero F, Campbell EM. 2010. Identification of residues within the L2 region of rhesus TRIM5alpha that are required for retroviral restriction and cytoplasmic body localization. Virology 405:259-266. http://dx.doi.org/10.1016/j.virol.2010.06.015.
33. Sanjana NE, Shalem O, Zhang F. 2014. Improved vectors and genomewide libraries for CRISPR screening. Nat Methods 11:783-784. http://dx.doi.org/10.1038/nmeth.3047.
34. Zufferey R, Dull T, Mandel RJ, Bukovsky A, Quiroz D, Naldini L, Trono D. 1998. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 72:9873-9880.
35. Campbell EM, Nunez R, Hope TJ. 2004. Disruption of the actin cytoskeleton can complement the ability of Nef to enhance human immunodeficiency virus type 1 infectivity. J Virol 78:5745-5755. http://dx.doi.org/10.1128/JVI.78.11.5745-5755.2004.
36. Lukic Z, Campbell EM. 2012. The cell biology of TRIM5alpha. Curr HIV/AIDS Rep 9:73-80. http://dx.doi.org/10.1007/s11904-011-0102-8.
37. Bowman EJ, Siebers A, Altendorf K. 1988. Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc Natl Acad Sci U S A 85:7972-7976. http://dx.doi.org/10.1073/pnas.85.21.7972.
38. Klionsky DJ, Elazar Z, Seglen PO, Rubinsztein DC. 2008. Does bafilomycin A1 block the fusion of autophagosomes with lysosomes? Autophagy 4:849-850. http://dx.doi.org/10.4161/auto.6845.
39. Yamamoto A, Tagawa Y, Yoshimori T, Moriyama Y, Masaki R, Tashiro Y. 1998. Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct Funct 23:33-42.
40. Diaz-Griffero F, Li X, Javanbakht H, Song B, Welikala S, Stremlau M, Sodroski J. 2006. Rapid turnover and polyubiquitylation of the retroviral restriction factor TRIM5. Virology 349:300-315. http://dx.doi.org/10.1016/j.virol.2005.12.040.
41. Perron MJ, Stremlau M, Song B, Ulm W, Mulligan RC, Sodroski J. 2004. TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells. Proc Natl Acad Sci U S A 101:11827-11832. http://dx.doi.org/10.1073/pnas.0403364101.
42. Perez-Caballero D, Hatziioannou T, Zhang F, Cowan S, Bieniasz PD. 2005. Restriction of human immunodeficiency virus type 1 by TRIMCypA occurs with rapid kinetics and independently of cytoplasmic bodies, ubiquitin, and proteasome activity. J Virol 79:15567-15572. http://dx.doi.org/10.1128/JVI.79.24.15567-15572.2005.
43. Bienvenut WV, Sumpton D, Martinez A, Lilla S, Espagne C, Meinnel T, Giglione C. 2012. Comparative large scale characterization of plant versus mammal proteins reveals similar and idiosyncratic N-alpha-acetylation features. Mol Cell Proteomics 11:M111.015131. http://dx.doi.org/10.1074/mcp. M111.015131.
44. Yudina Z, Roa A, Johnson R, Biris N, de Souza Aranha Vieira DA, Tsiperson V, Reszka N, Taylor AB, Hart PJ, Demeler B, Diaz-Griffero F, Ivanov DN. 2015. RING dimerization links higher-order assembly of TRIM5alpha to synthesis of K63-linked polyubiquitin. Cell Rep 12:788-797. http://dx.doi.org/10.1016/j.celrep.2015.06.072.